Journal
BRAIN SCIENCES
Volume 13, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/brainsci13091305
Keywords
neurostimulation; gene editing; optogenetics; treatment resistance; drug-resistant epilepsy; seizure mechanisms; cannabinoids; personalized therapy
Categories
Ask authors/readers for more resources
This comprehensive review explores innovative therapies for epilepsy management, including responsive neurostimulation, vagus nerve stimulation, deep brain stimulation, gene therapies, and optogenetics. It also discusses adjunctive therapies like cannabidiol and the ketogenic diet. The importance of staying updated with emerging trends in epilepsy management is emphasized, along with the hope for improved therapeutic options.
Epilepsy is a complex neurological disorder affecting millions worldwide, with a substantial number of patients facing drug-resistant epilepsy. This comprehensive review explores innovative therapies for epilepsy management, focusing on their principles, clinical evidence, and potential applications. Traditional antiseizure medications (ASMs) form the cornerstone of epilepsy treatment, but their limitations necessitate alternative approaches. The review delves into cutting-edge therapies such as responsive neurostimulation (RNS), vagus nerve stimulation (VNS), and deep brain stimulation (DBS), highlighting their mechanisms of action and promising clinical outcomes. Additionally, the potential of gene therapies and optogenetics in epilepsy research is discussed, revealing groundbreaking findings that shed light on seizure mechanisms. Insights into cannabidiol (CBD) and the ketogenic diet as adjunctive therapies further broaden the spectrum of epilepsy management. Challenges in achieving seizure control with traditional therapies, including treatment resistance and individual variability, are addressed. The importance of staying updated with emerging trends in epilepsy management is emphasized, along with the hope for improved therapeutic options. Future research directions, such as combining therapies, AI applications, and non-invasive optogenetics, hold promise for personalized and effective epilepsy treatment. As the field advances, collaboration among researchers of natural and synthetic biochemistry, clinicians from different streams and various forms of medicine, and patients will drive progress toward better seizure control and a higher quality of life for individuals living with epilepsy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available